Hangzhou Sumgen Biotech Co., Ltd.

This early-stage study tests a new drug called SG301 in 61 people with blood cancers like multiple myeloma that have returned or not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. Researchers will also look at how the drug mo…

This early-stage study tests a new drug called SG301, given as a shot under the skin, to see if it is safe for people with systemic lupus erythematosus (SLE). The study first gives a single dose to healthy volunteers, then multiple doses to lupus patients. About 48 people will ta…

This early-stage study tests a new drug called SG2918 in 17 people with advanced cancers that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the right dose. Researchers will also look for early signs that the drug might shri…